title: Thrombotic events in patients with systemic sclerosis treated with iloprost.
authors.affiliation: IRCCS Ospedale Maggiore Policlinico, Milano, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Tedeschi
authors.forename: P L
authors.initials: PL
authors.lastname: Meroni
authors.forename: N
authors.initials: N
authors.lastname: Del Papa
authors.forename: C
authors.initials: C
authors.lastname: Salmaso
authors.forename: C
authors.initials: C
authors.lastname: Boschetti
authors.forename: A
authors.initials: A
authors.lastname: Miadonna
mesh_terms: D005260:Female; D006801:Humans; D016285:Iloprost / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D012595:Scleroderma, Systemic / Q000188:drug therapy*; D013927:Thrombosis / Q000139:chemically induced*; D014665:Vasodilator Agents / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D010975:Platelet Aggregation Inhibitors; D014665:Vasodilator Agents; D016285:Iloprost